Immune Score Predicts Outcomes of Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy.
Wei ZouMeng-Long ZhouLing-Yi ZhangJia-Ning YangWang YangYa-Qi WangYu-Xi YiGui-Chao LiZhen ZhangPublished in: Journal of oncology (2021)
IS is a strong predictive factor for both DFS and OS in GC patients treated with adjuvant chemoradiotherapy, which may complement the traditional pTNM staging system.